BKV Q3 adjusted EBITDAX rises to $132.7 million; GAAP net income falls to $29.4 million
BKV reported third-quarter 2026 results showing adjusted EBITDAX attributable to BKV of $132.7 million, up from $101.3 million a year earlier, and adjusted EPS of $0.36 versus $0.27. GAAP net income attributable to BKV fell to $29.4 million from $83.5 million, and the company also announced a cost reimbursement agreement covering up to approximately $179 million for expanded modular power development in Temple, Texas.
Key points
- Net income attributable to BKV was $29.4 million, or $0.27 per diluted share, versus $83.5 million in the third quarter of 2025.
- Adjusted EBITDAX attributable to BKV was $132.7 million, versus $101.3 million a year earlier; adjusted EPS was $0.36 versus $0.27.
- A cost reimbursement agreement with a Leading Frontier AI Lab covers up to approximately $179 million if offtake arrangements are not agreed by November 18, 2026, with an aggregate cap of $374.1 million.
- Fourth-quarter 2026 guidance calls for total capital expenditures of $315 million to $385 million and net production of 1,010 to 1,030 MMcfe/d.
The filing
Written by AI on Nov 9, 2026, 11:44 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 05, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.